Sartorius Stedim Biotech S.A.

SDMHF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$75$93$115$41
Dep. & Amort.$93$78$77$81
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$8-$57-$35$139
Other Non-Cash-$105$11-$38$25
Operating Cash Flow$71$125$120$285
Investing Activities
PP&E Inv.-$158-$76-$65-$80
Net Acquisitions$1-$1$0$0
Inv. Purchases-$3$0$0-$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$0
Investing Cash Flow-$160-$77-$65-$80
Financing Activities
Debt Repay.-$377$13-$14-$5
Stock Issued$0$0$0$2
Stock Repurch.-$4$1-$2$1
Dividends Paid$0-$67$0$0
Other Fin. Act.$0-$0-$10-$9
Financing Cash Flow-$380-$53-$26-$11
Forex Effect-$3-$3-$0$3
Net Chg. in Cash-$473-$8$29$196
Supplemental Information
Beg. Cash$824$708$679$483
End Cash$351$699$708$679
Free Cash Flow-$87$49$55$205
Sartorius Stedim Biotech S.A. (SDMHF) Financial Statements & Key Stats | AlphaPilot